Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Editorial

Editorial policy

Last updated Nov 2026

MRD Watch publishes sourced, fact-only notes on molecular residual disease, ctDNA, and related biomarkers. It is not medical advice.

How an item gets in

  • Primary sources come first: the paper, the trial registry, the regulator, or the meeting abstract.
  • The note states what that source says. It does not rank tests or tell a reader what treatment to take.
  • Explainers written by the site do not use vendor branding or links to company marketing pages. Assay names stay where a table is comparing published limits, or where a paper or trial title uses them.

Corrections

If a note is wrong, it is corrected on the page and the change is dated. Write through the contact form with the URL and the source that shows the error.

Sponsorship

A sponsor may buy the labeled bar on the site and the labeled line in the Friday email. Sponsorship does not choose, edit, or suppress items. Sponsored placements are labeled.

The editor’s roles are on the disclosure page.